PF-Atlas › Clinical Trials › PRIME-AATD

Prime Medicine Prime Editing for AATD

PM-101 · Prime Editing · Phase 1

Registry ID
PRIME-AATD
Phase
Phase 1
Status
Not yet recruiting
Drug / intervention
PM-101
Mechanism
Prime Editing
Sponsor
Prime Medicine
Start
2026-01

About this trial

PM-101 is evaluated in PRIME-AATD, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Prime Medicine, targeting prime editing. Current status: Not yet recruiting.

View PRIME-AATD on ClinicalTrials.gov →

Explore related

All PM-101 trialsPrime Editing mechanismAll IPF trials
Medical disclaimer. This page summarizes public trial data for PRIME-AATD for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.